Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Bihrer, Verena ^a   Waidmann, Oliver ^a   Friedrich Rust, Mireen ^a   Forestier, Nicole ^a   Susser, Simone ^a   Haupenthal, Jörg ^a,b   Welker, Martin ^a   Shi, Ying ^a   Peveling Oberhag, Jan ^a   Polta, Andreas ^a   von Wagner, Michael ^a   Radeke, Heinfried H ^a   Sarrazin, Christoph ^a   Trojan, Jörg ^a   Zeuzem, Stefan ^a   Kronenberger, Bernd ^a   Piiper, Albrecht ^a  

^a GOETHE UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; MICRORNA; MICRORNA 16; MICRORNA 21; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MIRN21 MICRORNA, HUMAN; SERUM ALBUMIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD LEVEL; CANCER GRADING; CANCER STAGING; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERNATIONAL NORMALIZED RATIO; LIVER CELL CARCINOMA; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; NECROINFLAMMATION; NONHUMAN; REFERENCE VALUE; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; BLOOD; COHORT ANALYSIS; ENZYMOLOGY; INFLAMMATION; LIVER TUMOR; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NECROSIS; PATHOLOGY; REPRODUCIBILITY;

HEPATITIS C VIRUS;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS C, CHRONIC; HUMANS; INFLAMMATION; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NECROSIS; REPRODUCIBILITY OF RESULTS; SERUM ALBUMIN;

EID: 80055103381     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026971     Document Type: Article

References (33)

1. El-Serag HB, Marrero JA, Rudolph L, Reddy KR, (2008) Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 134: 1752-1763.
2. Zinkin NT, Grall F, Bhaskar K, Otu HH, Spentzos D, et al. (2008) Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Clin Cancer Res 14: 470-477.
3. Du T, Zamore PD, (2005) microPrimer: the biogenesis and function of microRNA. Development 132: 4645-4652.
4. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261.
5. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518.
6. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, et al. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658.
7. Varnholt H, (2008) The role of microRNAs in primary liver cancer. Ann Hepatol 7: 104-113.
8. Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, et al. (2008) MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47: 1955-1963.
9. Marquez RT, Bandyopadhyay S, Wendlandt EB, Keck K, Hoffer BA, et al. (2010) Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Lab Invest 90: 1727-1736.
10. Medina PP, Nolde M, Slack FJ, (2010) OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467: 86-90.
11. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, et al. (2008) Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 141: 672-675.
12. Zhang HL, Yang LF, Zhu Y, Yao XD, Zhang SL, et al. (2011) Serum miRNA-21: Elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy. Prostate 71: 326-331.
13. Asaga S, Kuo C, Nguyen T, Terpenning M, Giuliano AE, et al. (2011) Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chem 57: 84-91.
14. Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, et al. (2010) miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 207: 1589-1597.
15. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, et al. (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980-984.
16. Matsuzaki K, Murata M, Yoshida K, Sekimoto G, Uemura Y, et al. (2007) Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma. Hepatology 46: 48-57.
17. Dooley S, Hamzavi J, Ciuclan L, Godoy P, Ilkavets I, et al. (2008) Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage. Gastroenterology 135: 642-659.
18. Davis BN, Hilyard AC, Lagna G, Hata A, (2008) SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454: 56-61.
19. Tomimaru Y, Eguchi H, Nagano H, Wada H, Kobayashi S, et al. (2011) Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. J Hepatol doi:10.1016/j.jhep.2011.04.026.
20. Ishak K, Baptista A, Bianchi L, Callea F, Groote JD, et al. (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22: 696-699.
21. Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K, (2010) STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 39: 493-506.
22. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, et al. (2008) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283: 1026-1033.
23. Xu J, Wu C, Che X, Wang L, Yu D, et al. (2011) Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 50: 136-142.
24. Wang K, Zhang S, Weber J, Baxter D, Galas DJ, (2010) Export of microRNAs and microRNA-protective protein by mammalian cells. Nucl Acids Res 38: 7248-7259.
25. Arroyo JD, Chevilleta JR, Kroha EM, Rufa IK, Colin C, et al. (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 108: 5003-5008.
26. Yamamichi N, Shimomura R, Inada K, Sakurai K, Haraguchi T, et al. (2009) Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. Clin Cancer Res 15: 4009-4016.
27. Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L, (2011) Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease. PLoS One 6: e23937.
28. Poynard T, Bedossa P, Opolon P, (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349: 825-832.
29. Zhang Y, Jia Y, Zheng R, Guo Y, Wang Y, et al. (2010) Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 56: 1830-1838.
30. Qu KZ, Zhang K, Li H, Afdhal NH, Albitar M, (2011) Circulating microRNAs as biomarkers for hepatocellular carcinoma. J Clin Gastroenterol 45: 355-360.
31. Bihrer V, Friedrich-Rust M, Kronenberger B, Forestier N, Haupenthal J, et al. (2011) Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. Am J Gastroenterol 106: 1663-1669.
32. Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, et al. (2007) miRNA profiling of naïve, effector and memory CD8 T cells. PLoS One 2: e1020.
33. Zen K, Zhang CY, (2010) Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev [Epub ahead of print].